Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis.

Hsiao-Ling ChenTun-Chieh ChenHsiu-Mei ChangYung-Shun JuanWei-Hsuan HuangHung-Fang PanYong-Chieh ChangChiou-Mei WuYa-Ling WangHsiang Ying Lee

Published in: World journal of urology (2018)

Mirabegron was not inferior effective in improving OAB symptoms compared with antimuscarinic agents. In addition, mirabegron presented lower incidence of dry mouth and not higher risk for hypertension. Therefore, mirabegron has potential to be an alternative therapeutic option for OAB control.

Keyphrases

blood pressure
risk factors
sleep quality
climate change
arterial hypertension